Livio Trusolino 个人学术档案

引用次数

	总计	2019 年至今
引用	21728	11393
h 指数	69	50
i10 指数	114	93

2300

1150

575

1725

1999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202459 80 83 149 187 202 226 233 250 264 275 405 445 578 672 876 1010 1196 1447 1392 1730 1927 2245 2221 2187 1071

开放获取的出版物数量

查看全部

80 篇文章

3 篇文章

可查看的文章

无法查看的文章

根据资助方的强制性开放获取政策

合著作者

Andrea BertottiUniversity of Torino - School of Medicine在 ircc.it 的电子邮件经过验证
francesco sassiIRCC-University of Torino School of Medicine, Laboratory of Molecular Pharmacology Italy在 ircc.it 的电子邮件经过验证
Enzo MedicoProfessor of Histology, University of Torino and Head of the Laboratory of Oncogenomics, Candiolo在 ircc.it 的电子邮件经过验证
Salvatore SienaUniversità degli Studi di Milano, Dipartimento di Oncologia, Ospedale Niguarda, Milano, Italy在 unimi.it 的电子邮件经过验证
Claudio IsellaIRCC在 ircc.it 的电子邮件经过验证
Andrea Sartore-BianchiClinical Molecular Oncology, Niguarda Cancer Center, Milano - Italy在 ospedaleniguarda.it 的电子邮件经过验证
Luca LazzariIFOM - FIRC Institute of Molecular Oncology在 ifom.eu 的电子邮件经过验证
Fortunato CiardielloProfessore di oncologia medica, seconda università di napoli在 unina2.it 的电子邮件经过验证
Jos JonkersSenior Group Leader, Division of Molecular Pathology, Netherlands Cancer Institute, Oncode Institute在 nki.nl 的电子邮件经过验证
Simona CorsoUniversity of Torino在 ircc.it 的电子邮件经过验证
Charlotte RolnyAssociate professor of tumor biology, PI at Lund University and Karolinska Institutet, Sweden在 med.lu.se 的电子邮件经过验证
Alessandro AMOREOspedale Regina Margherita Torino, Università degli studi Torino在 unito.it 的电子邮件经过验证
Massimiliano MazzoneGroup Leader, Vesalius Research Center在 vib-kuleuven.be 的电子邮件经过验证
Lorenzo CapussottiChief of the Surgical Deparment- Ospedale Mauriziano "Umberto I" Torino在 mauriziano.it 的电子邮件经过验证
Andrea CasazzaDirector Biology @ Montis Bioscience, Belgium在 montisbio.com 的电子邮件经过验证
Guido SeriniProfessor, University of Torino School of Medicine | Candiolo Cancer Institute IRCCS在 ircc.it 的电子邮件经过验证
Dario RiberoDirigente Medico I livello, Divisione di Chirurgia Generale ed Oncologica, Ospedale Mauriziano Umberto I在 mauriziano.it 的电子邮件经过验证
Lodewyk WesselsProfessor of Computational Cancer Biology在 nki.nl 的电子邮件经过验证
Giuseppe Bassoprofessor of pediatrics university padua在 unipd.it 的电子邮件经过验证
Antonio PalumboUniversità di Torino; Torino Italy在 unito.it 的电子邮件经过验证

关注

Livio Trusolino

Professor, University of Torino School of Medicine, Italy

在 ircc.it 的电子邮件经过验证 - 首页

Targeted anti-cancer therapies animal models oncogenic signal transduction pathways


标题按引用次数排序按年份排序按标题排序	引用次数引用次数	年份
Patient-derived xenograft models: an emerging platform for translational cancer research M Hidalgo, F Amant, AV Biankin, E Budinská, AT Byrne, C Caldas, ... Cancer discovery 4 (9), 998-1013, 2014	1664	2014
MET signalling: principles and functions in development, organ regeneration and cancer L Trusolino, A Bertotti, PM Comoglio Nature reviews Molecular cell biology 11 (12), 834-848, 2010	1337	2010
Prioritization of cancer therapeutic targets using CRISPR–Cas9 screens FM Behan, F Iorio, G Picco, E Gonçalves, CM Beaver, G Migliardi, ... Nature 568 (7753), 511-516, 2019	1042	2019
A molecularly annotated platform of patient-derived xenografts (“xenopatients”) identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer A Bertotti, G Migliardi, F Galimi, F Sassi, D Torti, C Isella, D Corà, ... Cancer discovery 1 (6), 508-523, 2011	1012	2011
Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of … A Sartore-Bianchi, L Trusolino, C Martino, K Bencardino, S Lonardi, ... The Lancet Oncology 17 (6), 738-746, 2016	965	2016
Drug development of MET inhibitors: targeting oncogene addiction and expedience PM Comoglio, S Giordano, L Trusolino Nature reviews Drug discovery 7 (6), 504-516, 2008	964	2008
Scatter-factor and semaphorin receptors: cell signalling for invasive growth L Trusolino, PM Comoglio Nature reviews cancer 2 (4), 289-300, 2002	905	2002
Amplification of the MET Receptor Drives Resistance to Anti-EGFR Therapies in Colorectal Cancer A Bardelli, S Corso, A Bertotti, S Hobor, E Valtorta, G Siravegna, ... Cancer discovery 3 (6), 658-673, 2013	697	2013
Interrogating open issues in cancer precision medicine with patient-derived xenografts AT Byrne, DG Alférez, F Amant, D Annibali, J Arribas, AV Biankin, A Bruna, ... Nature Reviews Cancer 17 (4), 254-268, 2017	660	2017
Stromal contribution to the colorectal cancer transcriptome C Isella, A Terrasi, SE Bellomo, C Petti, G Galatola, A Muratore, A Mellano, ... Nature genetics 47 (4), 312-319, 2015	645	2015
A signaling adapter function for α6β4 integrin in the control of HGF-dependent invasive growth L Trusolino, A Bertotti, PM Comoglio Cell 107 (5), 643-654, 2001	567	2001
The genomic landscape of response to EGFR blockade in colorectal cancer A Bertotti, E Papp, S Jones, V Adleff, V Anagnostou, B Lupo, M Sausen, ... Nature 526 (7572), 263-267, 2015	461	2015
The Met tyrosine kinase receptor in development and cancer A Gentile, L Trusolino, PM Comoglio Cancer and metastasis reviews 27, 85-94, 2008	384	2008
Intrinsic resistance to MEK inhibition in KRAS mutant lung and colon cancer through transcriptional induction of ERBB3 C Sun, S Hobor, A Bertotti, D Zecchin, S Huang, F Galimi, F Cottino, ... Cell reports 7 (1), 86-93, 2014	349	2014
Adaptive mutability of colorectal cancers in response to targeted therapies M Russo, G Crisafulli, A Sogari, NM Reilly, S Arena, S Lamba, A Bartolini, ... Science 366 (6472), 1473-1480, 2019	341	2019
Hypertension-associated point mutations in the adducin alpha and beta subunits affect actin cytoskeleton and ion transport. G Tripodi, F Valtorta, L Torielli, E Chieregatti, S Salardi, L Trusolino, ... The Journal of clinical investigation 97 (12), 2815-2822, 1996	327	1996
Interactions between growth factor receptors and adhesion molecules: breaking the rules PM Comoglio, C Boccaccio, L Trusolino Current opinion in cell biology 15 (5), 565-571, 2003	326	2003
EGFR Blockade Reverts Resistance to KRAS^G12C Inhibition in Colorectal Cancer V Amodio, R Yaeger, P Arcella, C Cancelliere, S Lamba, A Lorenzato, ... Cancer discovery 10 (8), 1129-1139, 2020	302	2020
Known and novel roles of the MET oncogene in cancer: a coherent approach to targeted therapy PM Comoglio, L Trusolino, C Boccaccio Nature Reviews Cancer 18 (6), 341-358, 2018	302	2018
Oncogene addiction as a foundational rationale for targeted anti‐cancer therapy: promises and perils D Torti, L Trusolino EMBO molecular medicine 3 (11), 623-636, 2011	300	2011

系统目前无法执行此操作，请稍后再试。

文章 1–20

每年引用数

重复的引用

合并的引用

添加合著者合著作者

上传 PDF

关注此作者

引用次数

合著作者

引用